Nika Pharmaceuticals Inc (NIKA)

Nika Pharmaceuticals Inc. recorded insider activity involving Savov Dimitar Slavchev, who executed a sale of two million shares on March 18, 2025. Subsequently, the officer filed a proposed sale for ten million shares on April 16, 2025. These transactions represent the most recent documented movements by company leadership.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: NIKA Exchange: PNK

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Nika Pharmaceuticals Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Savov Dimitar Slavchev Officer; Director; 10% Stockholder Executive Director Large shareholder

Transaction date 16 Apr 2025

Proposed sale

Price

336.78

Quantity 36,450

Value US$2,840,517

Comments Filing

Savov Dimitar Slavchev CEO, CFO, President Executive Director Large shareholder

Transaction date 18 Mar 2025

Sale

Price

44.10

Quantity 1,958 -4.7%

Value US$2,675,423

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-04-16	2025-04-16	PrS Proposed sale	Savov Dimitar Slavchev Officer; Director; 10% Stockholder Executive Director Large shareholder	36,450 336.78 US$2,840,517	36,450	336.78	US$2,840,517
2025-03-19	2025-03-18	S Sale	Savov Dimitar Slavchev CEO, CFO, President Executive Director Large shareholder	1,958 -4.7% 44.10 US$2,675,423	1,958 -4.7%	44.10	US$2,675,423